FierceBiotech Dec 5, 2025 Encoded deciphers path to pivotal trial with phase 1/2 Dravet gene therapy data
FierceBiotech Dec 5, 2025 'Unprecedented turmoil' engulfing FDA threatens public health: mRNA coalition speaks out
FierceBiotech Dec 5, 2025 How AI and real-world evidence are powering smarter decisions across the drug and device development lifecycle
FierceBiotech Dec 5, 2025 Praxis claims efficacy success in phase 2 seizure trial, setting up approval talks with FDA
FierceBiotech Dec 5, 2025 Pfizer Ventures gets behind Chinese biotech's $100M series A to boost R&D hub's capability
FierceBiotech Dec 4, 2025 GE HealthCare, Mayo Clinic launch digital twin project for personalizing radiation cancer therapy
FierceBiotech Dec 4, 2025 Paradigm Health raises $78M to revamp clinical research process, inks deal with Roche’s Flatiron
FierceBiotech Dec 4, 2025 After dodging Biosecure threat, WuXi AppTec faces new security scrutiny from Pentagon: Bloomberg
FierceBiotech Dec 4, 2025 Crescent waxes pipeline with $80M Kelun deal, bagging ADC to pair with PD-1xVEGF bispecific
FierceBiotech Dec 4, 2025 Royalty pens $275M financing deal for Denali drug awaiting delayed FDA decision
FierceBiotech Dec 4, 2025 After more than 20 years, Medtronic claims deep brain stimulation approval for dystonia
FierceBiotech Dec 4, 2025 A dozen former FDA commissioners blast Prasad's proposed vaccine policy changes